Literature DB >> 24946950

Ascites-induced shift along epithelial-mesenchymal spectrum in ovarian cancer cells: enhancement of their invasive behavior partly dependant on αv integrins.

L Carduner1, J Leroy-Dudal, C R Picot, O Gallet, F Carreiras, S Kellouche.   

Abstract

At least one-third of patients with epithelial ovarian cancer (OC) present ascites at diagnosis and almost all have ascites at recurrence. The presence of ascites, which acts as a dynamic reservoir of active molecules and cellular components, correlates with the OC peritoneal metastasis and is associated with poor prognosis. Since epithelial-mesenchymal transition (EMT) is involved in different phases of OC progression, we have investigated the effect of the unique ascitic tumor microenvironment on the EMT status and the behavior of OC cells. The exposure of three OC cell lines to ascites leads to changes in cellular morphologies. Within ascites, OC cells harboring an initial intermediate epithelial phenotype are characterized by marked dislocation of epithelial markers (E-cadherin, ZO-1 staining) while OC cells initially harboring an intermediate mesenchymal phenotype strengthen their mesenchymal markers (N-cadherin, vimentin). Ascites differentially triggers a dissemination phenotype related to the initial cell features by either allowing the proliferation and the formation of spheroids and the extension of colonies for cells that present an initial epithelial intermediate phenotype, or favoring the migration of cells with a mesenchymal intermediate phenotype. In an ascitic microenvironment, a redeployment of αv integrins into cells was observed and the ascites-induced accentuation of the two different invasive phenotypes (i.e. spheroids formation or migration) was shown to involve αv integrins. Thus, ascites induces a shift toward an unstable intermediate state of the epithelial-mesenchymal spectrum and confers a more aggressive cell behavior that takes on a different pathway based on the initial epithelial-mesenchymal cell features.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24946950     DOI: 10.1007/s10585-014-9658-1

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  55 in total

Review 1.  Ovarian surface epithelium: biology, endocrinology, and pathology.

Authors:  N Auersperg; A S Wong; K C Choi; S K Kang; P C Leung
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  The morphological and molecular features of the epithelial-to-mesenchymal transition.

Authors:  Gema Moreno-Bueno; Héctor Peinado; Patricia Molina; David Olmeda; Eva Cubillo; Vanesa Santos; José Palacios; Francisco Portillo; Amparo Cano
Journal:  Nat Protoc       Date:  2009-10-15       Impact factor: 13.491

3.  Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.

Authors:  Laura Rosanò; Francesca Spinella; Valeriana Di Castro; Maria Rita Nicotra; Shoukat Dedhar; Antonio Garcia de Herreros; Pier Giorgio Natali; Anna Bagnato
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

4.  Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation.

Authors:  D Lane; N Goncharenko-Khaider; C Rancourt; A Piché
Journal:  Oncogene       Date:  2010-04-19       Impact factor: 9.867

5.  Cadherin expression in ovarian carcinoma and malignant mesothelioma cell effusions.

Authors:  Stine Sivertsen; Aasmund Berner; Claire W Michael; Carlos Bedrossian; Ben Davidson
Journal:  Acta Cytol       Date:  2006 Nov-Dec       Impact factor: 2.319

6.  The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

Authors:  Hilary A Kenny; Swayamjot Kaur; Lisa M Coussens; Ernst Lengyel
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

7.  Vitronectin and its receptors partly mediate adhesion of ovarian cancer cells to peritoneal mesothelium in vitro.

Authors:  Loraine Heyman; Sabrina Kellouche; Julien Fernandes; Soizic Dutoit; Laurent Poulain; Franck Carreiras
Journal:  Tumour Biol       Date:  2008-09-09

Review 8.  Multicellular spheroids in ovarian cancer metastases: Biology and pathology.

Authors:  Kristy Shield; M Leigh Ackland; Nuzhat Ahmed; Gregory E Rice
Journal:  Gynecol Oncol       Date:  2009-01-10       Impact factor: 5.482

9.  Epithelial-mesenchymal transition in ovarian carcinoma.

Authors:  Ben Davidson; Claes G Tropé; Reuven Reich
Journal:  Front Oncol       Date:  2012-04-10       Impact factor: 6.244

Review 10.  Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research.

Authors:  Nuzhat Ahmed; Kaye L Stenvers
Journal:  Front Oncol       Date:  2013-09-25       Impact factor: 6.244

View more
  18 in total

1.  The Interplay Between Epithelial-Mesenchymal Transition (EMT) and the Thyroid Hormones-αvβ3 Axis in Ovarian Cancer.

Authors:  Chen Weingarten; Yonatan Jenudi; Rami Yair Tshuva; Dotan Moskovich; Adi Alfandari; Aleck Hercbergs; Paul J Davis; Martin Ellis; Osnat Ashur-Fabian
Journal:  Horm Cancer       Date:  2017-12-19       Impact factor: 3.869

2.  The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation.

Authors:  E Shinderman-Maman; K Cohen; C Weingarten; D Nabriski; O Twito; L Baraf; A Hercbergs; P J Davis; H Werner; M Ellis; O Ashur-Fabian
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

3.  Enhanced expression of αVβ3 integrin in villus and extravillous trophoblasts of placenta accreta.

Authors:  Omer Weitzner; Chen Seraya-Bareket; Tal Biron-Shental; Ami Fishamn; Yael Yagur; Keren Tzadikevitch-Geffen; Sivan Farladansky-Gershnabel; Debora Kidron; Martin Ellis; Osnat Ashur-Fabian
Journal:  Arch Gynecol Obstet       Date:  2020-10-28       Impact factor: 2.344

Review 4.  IL-10 Signaling in the Tumor Microenvironment of Ovarian Cancer.

Authors:  Ramesh B Batchu; Oksana V Gruzdyn; Bala K Kolli; Rajesh Dachepalli; Prem S Umar; Sameer K Rai; Namrata Singh; Pavan S Tavva; Donald W Weaver; Scott A Gruber
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Calcium Mobilization and Inhibition of Akt Reduced the Binding of PEO-1 Cells to Fibronectin.

Authors:  Seda Mehtap Sari Kiliçaslan; Aysun Ayrim; Elif Apaydin; Zerrin Incesu
Journal:  Turk J Pharm Sci       Date:  2018-04-02

6.  Understanding the effect of mechanical forces on ovarian cancer progression.

Authors:  A Martinez; M Buckley; C B Scalise; A A Katre; J J Dholakia; D Crossman; M J Birrer; J L Berry; R C Arend
Journal:  Gynecol Oncol       Date:  2021-04-20       Impact factor: 5.304

7.  Discover the molecular biomarker associated with cell death and extracellular matrix module in ovarian cancer.

Authors:  Qiang Liu; Jianxin Guo; Jinghong Cui; Jing Wang; Ping Yi
Journal:  Biomed Res Int       Date:  2015-03-16       Impact factor: 3.411

8.  SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance.

Authors:  J N Sheets; M Iwanicki; J F Liu; B E Howitt; M S Hirsch; J A A Gubbels; R Drapkin; K A Egland
Journal:  Oncogenesis       Date:  2016-10-24       Impact factor: 7.485

9.  CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.

Authors:  Amanda Sosulski; Heiko Horn; Lihua Zhang; Caroline Coletti; Vinod Vathipadiekal; Cesar M Castro; Michael J Birrer; Osamu Nagano; Hideyuki Saya; Kasper Lage; Patricia K Donahoe; David Pépin
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

Review 10.  Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells.

Authors:  Francesca Roggiani; Delia Mezzanzanica; Katia Rea; Antonella Tomassetti
Journal:  Int J Mol Sci       Date:  2016-08-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.